196 related articles for article (PubMed ID: 35241542)
1. Background Parenchymal Enhancement in Contrast-enhanced Spectral Mammography: A Retrospective Analysis and a Pictorial Review of Clinical Cases.
Meucci R; Pistolese CA; Perretta T; Vanni G; Beninati E; DI Tosto F; Serio ML; Caliandro A; Materazzo M; Pellicciaro M; Buonomo OC
In Vivo; 2022; 36(2):853-858. PubMed ID: 35241542
[TBL] [Abstract][Full Text] [Related]
2. Could parenchymal enhancement on contrast-enhanced spectral mammography (CESM) represent a new breast cancer risk factor? Correlation with known radiology risk factors.
Savaridas SL; Taylor DB; Gunawardana D; Phillips M
Clin Radiol; 2017 Dec; 72(12):1085.e1-1085.e9. PubMed ID: 28870431
[TBL] [Abstract][Full Text] [Related]
3. Background Parenchymal Enhancement at Contrast-Enhanced Spectral Mammography (CESM) as a Breast Cancer Risk Factor.
Sorin V; Yagil Y; Shalmon A; Gotlieb M; Faermann R; Halshtok-Neiman O; Sklair-Levy M
Acad Radiol; 2020 Sep; 27(9):1234-1240. PubMed ID: 31812577
[TBL] [Abstract][Full Text] [Related]
4. Analysis of background parenchymal enhancement (BPE) on contrast enhanced spectral mammography compared with magnetic resonance imaging.
Luczynska E; Pawlak M; Piegza T; Popiela TJ; Heinze S; Dyczek S; Rudnicki W
Ginekol Pol; 2021; 92(2):92-97. PubMed ID: 33448005
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Background Parenchymal Enhancement at Contrast-enhanced Spectral Mammography and Breast MR Imaging.
Sogani J; Morris EA; Kaplan JB; D'Alessio D; Goldman D; Moskowitz CS; Jochelson MS
Radiology; 2017 Jan; 282(1):63-73. PubMed ID: 27379544
[TBL] [Abstract][Full Text] [Related]
6. Qualitative assessments of density and background parenchymal enhancement on contrast-enhanced spectral mammography associated with breast cancer risk in high-risk women.
Xu C; Jiang M; Lin F; Zhang K; Xie H; Lv W; Ji H; Mao N
Br J Radiol; 2023 Aug; 96(1148):20220051. PubMed ID: 37227804
[TBL] [Abstract][Full Text] [Related]
7. Background parenchymal enhancement on contrast-enhanced spectral mammography does not represent an influencing factor for breast cancer: A preliminary study.
Yu L; Wang Y; Xing D; Gong P; Chen Q; Lv Y
Medicine (Baltimore); 2020 Dec; 99(52):e23857. PubMed ID: 33350778
[TBL] [Abstract][Full Text] [Related]
8. Contrast-enhanced spectral mammography in recalls from the Dutch breast cancer screening program: validation of results in a large multireader, multicase study.
Lalji UC; Houben IP; Prevos R; Gommers S; van Goethem M; Vanwetswinkel S; Pijnappel R; Steeman R; Frotscher C; Mok W; Nelemans P; Smidt ML; Beets-Tan RG; Wildberger JE; Lobbes MB
Eur Radiol; 2016 Dec; 26(12):4371-4379. PubMed ID: 27097789
[TBL] [Abstract][Full Text] [Related]
9. Role of contrast-enhanced spectral mammography in the post biopsy management of B3 lesions: Preliminary results.
Bicchierai G; Nori J; De Benedetto D; Boeri C; Vanzi E; Bianchi S; Kaur Gill M; Cirone D; Miele V
Tumori; 2019 Oct; 105(5):378-387. PubMed ID: 30558495
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
[TBL] [Abstract][Full Text] [Related]
11. Background enhancement in contrast-enhanced spectral mammography (CESM): are there qualitative and quantitative differences between imaging systems?
Wessling D; Männlin S; Schwarz R; Hagen F; Brendlin A; Olthof SC; Hattermann V; Gassenmaier S; Herrmann J; Preibsch H
Eur Radiol; 2023 Apr; 33(4):2945-2953. PubMed ID: 36474057
[TBL] [Abstract][Full Text] [Related]
12. Contrast-enhanced spectral mammography vs. mammography and MRI - clinical performance in a multi-reader evaluation.
Fallenberg EM; Schmitzberger FF; Amer H; Ingold-Heppner B; Balleyguier C; Diekmann F; Engelken F; Mann RM; Renz DM; Bick U; Hamm B; Dromain C
Eur Radiol; 2017 Jul; 27(7):2752-2764. PubMed ID: 27896471
[TBL] [Abstract][Full Text] [Related]
13. Can Contrast-Enhanced Spectral Mammography (CESM) Reduce Benign Breast Biopsy?
Liew ALF; Lim HMY; Fok ECM; Loke SC; Tan EY; Chong BK; Lee YS; Chan PMY; Chotai N
Breast J; 2022; 2022():7087408. PubMed ID: 35711887
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced spectral mammography: A potential exclusion diagnosis modality in dense breast patients.
Qin Y; Liu Y; Zhang X; Zhao S; Zhong H; Huang J; Yu J
Cancer Med; 2020 Apr; 9(8):2653-2659. PubMed ID: 32074407
[TBL] [Abstract][Full Text] [Related]
15. Classification of contrast-enhanced spectral mammography (CESM) images.
Perek S; Kiryati N; Zimmerman-Moreno G; Sklair-Levy M; Konen E; Mayer A
Int J Comput Assist Radiol Surg; 2019 Feb; 14(2):249-257. PubMed ID: 30367322
[TBL] [Abstract][Full Text] [Related]
16. [Clinical value of suspicious calcification in the diagnosis and surgical treatment of breast lesions using contrast-enhanced spectral mammography].
Sun XF; Xing W; Yu SN; Sha YY; Pan L; Chen Q
Zhonghua Yi Xue Za Zhi; 2020 Jan; 100(1):42-46. PubMed ID: 31914557
[No Abstract] [Full Text] [Related]
17. Adding the power of iodinated contrast media to the credibility of mammography in breast cancer diagnosis.
Tsigginou A; Gkali C; Chalazonitis A; Feida E; Vlachos DE; Zagouri F; Rellias I; Dimitrakakis C
Br J Radiol; 2016 Nov; 89(1067):20160397. PubMed ID: 27452266
[TBL] [Abstract][Full Text] [Related]
18. Contrast-enhanced spectral mammography in patients referred from the breast cancer screening programme.
Lobbes MB; Lalji U; Houwers J; Nijssen EC; Nelemans PJ; van Roozendaal L; Smidt ML; Heuts E; Wildberger JE
Eur Radiol; 2014 Jul; 24(7):1668-76. PubMed ID: 24696228
[TBL] [Abstract][Full Text] [Related]
19. Preoperative staging by multimodal imaging in newly diagnosed breast cancer: Diagnostic performance of contrast-enhanced spectral mammography compared to conventional mammography, ultrasound, and MRI.
Daniaux M; Gruber L; De Zordo T; Geiger-Gritsch S; Amort B; Santner W; Egle D; Baltzer PAT
Eur J Radiol; 2023 Jun; 163():110838. PubMed ID: 37080064
[TBL] [Abstract][Full Text] [Related]
20. Factors Associated With Background Parenchymal Enhancement on Contrast-Enhanced Mammography.
Karimi Z; Phillips J; Slanetz P; Lotfi P; Dialani V; Karimova J; Mehta T
AJR Am J Roentgenol; 2021 Feb; 216(2):340-348. PubMed ID: 32755162
[No Abstract] [Full Text] [Related]
[Next] [New Search]
